Today, I'm joined by Ariel Garten, co-founder of Muse.

Using clinical-grade EEG technology, Muse's mental fitness headband tracks brain activity to offer insights on sleep, focus, meditation, and cognitive performance.

In this episode, we discuss making brain health monitoring accessible and actionable.

We also cover:

• Defining brain health as consumer metric

• Integrating with the preventative health ecosystem

• Research partnerships and novel treatment development

Subscribe to the podcast → insider.fitt.co/podcastSubscribe to our newsletter → insider.fitt.co/subscribeFollow us on LinkedIn → linkedin.com/company/fittinsider

Muse Website: choosemuse.com

Muse on Instagram: www.instagram.com/choosemuse/

Muse on X (Twitter): www.x.com/ChooseMuse

Muse on Facebook: www.facebook.com/choosemuse

Muse on LinkedIn: www.linkedin.com/company/interaxon-inc/

Muse on Youtube: www.youtube.com/user/interaXon

-

The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart workout solutions for fitness and health facilities. Fitt Talent: https://talent.fitt.co/ Consulting: https://consulting.fitt.co/ Investments: https://capital.fitt.co/

Chapters:

(00:00) Introduction

(00:15) Ariel's background and Muse technology overview

(02:30) Evolution from lab-based EEG to consumer device

(04:45) Defining brain health and consumer metrics

(07:00) Education challenges and multiple entry points for brain health

(10:00) FDA classification and medical-grade validation

(13:15) Working with researchers and clinicians for validation

(15:18) Leveraging massive brain datasets for insights

(17:36) Large brain model development and AI applications

(19:00) Research partnerships and novel treatment development

(21:45) Multi-market business model across consumer, clinical, and research

(25:46) Organic growth into clinical and research markets

(28:15) Integration with preventative health ecosystem

(31:00) Future of brain-computer interfaces and realistic timelines

(33:55) New Muse Athena device with enhanced brain monitoring

(35:00) Conclusion